Back to Journals » OncoTargets and Therapy » Volume 14
Study Protocol
Study on Efficacy and Safety of Low-Dose Apatinib Combined with Camrelizumab and SOX Regimen as First-Line Treatment of Locally Advanced and Unresectable Gastric/Gastroesophageal Junction Cancer: A Protocol for an Open-Label, Dose Escalation and Extension Phase Ib Clinical Trial
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
4,022 | Dovepress* | 3,554+ | 372 | 3,926 | |
PubMed Central* | 468 | 180 | 648 | ||
Totals | 4,022 | 552 | 4,574 | ||
*Since 21 September 2021 |
View citations on PubMed Central and Google Scholar